生育获得脐血行干细胞移植治疗重大遗传性疾病的风险和对策

The Risk and Countermeasure in the Treatment of Genetic Diseases by the Stem Cell Transplantation of Harvesting Cord Blood Stem Cells Through Birth

通过生育获得脐带血行干细胞移植是治疗重大疾病的一条可行之路,但在治疗遗传性疾病时,当事家庭、检测机构和医疗机构三方都存在着极大的风险,特别是当事家庭很有可能要承受精神和经济上的更大打击,而且客观上造成患病或者携带者人群的进一步扩大,成为一个不可忽视的社会问题。有必要进行充分的伦理思考后提出尽可能周全的办法,以降低各方面的风险。

The stem cell transplantation, by harvesting cord blood stem cells through birth, is a practical way in the treatment of main diseases. However, the family, the testing laborotory and the medical institution are all running a great risk in the treatment of genetic diseases. Especially for the family, they will facing bigger strikes in both in spirit and economy： It will also become a social problem that could not be neglected as the objective expansion of the patients or the acceptant. Therefore, it is necessary to work out an ethical countermeasure to reduce the risk for all aspects.